Deproteinized hemoderivative of calf blood injection for the treatment of Alzheimer disease

Objective: To observe the effects of deproteinized hemoderivative of calf blood injection(DHCBI) on Alzheimer disease.Methods: Sixty-six patients were randomly divided into control group and treatment group.The control group received the therapy of piracetam intravenous injection,and the treatment group received intravenous DHCBI.One course lasted fo two weeks,and then the therapeutic effects were observed.Results: The clinical symptoms and the plasma high-sensitivity C-reactive protein and various lipid indicators of the two groups improved(P<0.01),and there were more obvious effects in the treatment group(P<0.05-P<0.01).Conclusions: DHCBI can improve the plasma lipid and the inflammation levels of the elderly with Alzheimer disease.